MDMA Statement on House Ways and Means Committee Vote on Medical Device Tax Repeal
WASHINGTON, DC – Mark Leahey, President and CEO of the Medical Device Manufacturers Association (MDMA), issued the following statement today regarding the House Ways and Means Committee vote on H.R. 436, the "Protect Medical Innovation Act of 2011:"
“Today marks the first step towards repealing the 2.3 percent device tax, and we thank Congressman Erik Paulsen and all Members of Congress who are fighting on behalf of medical technologies and patient care.
“MDMA has long said that the device tax would hamper job creation and unfairly punish the dynamic American success story that is medical technology innovation. The growing price tag of this onerous tax is further proof that it will lead to more layoffs, larger cuts to R&D and less innovation – a perfect storm of unintended consequences.
“This issue not only impacts one of the United States’ most innovative industries, but is a perfect opportunity for Congress to work in a bipartisan manner to support the common goal of renewed job creation.
“MDMA is committed to working with Members of both parties and both Chambers to help ensure that this misguided policy is repealed. Simply put, the medical device tax will hurt manufacturing, stymie job growth and impede patient care, all at a time when we can least afford it.”